thiorphan has been researched along with Cardiac Remodeling, Ventricular in 2 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malek, V | 1 |
| Gaikwad, AB | 1 |
| Mishima, T | 1 |
| Tanimura, M | 1 |
| Suzuki, G | 1 |
| Todor, A | 1 |
| Sharov, VG | 1 |
| Tanhehco, EJ | 1 |
| Goldstein, S | 1 |
| Sabbah, HN | 1 |
2 other studies available for thiorphan and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy.
Topics: Acetylation; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Diabetes Mellitus, Experim | 2019 |
Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
Topics: Animals; Chronic Disease; Coronary Angiography; Dogs; Heart Failure; Hemodynamics; Myocytes, Cardiac | 2002 |